Gilead Sciences Investor
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Invests into
Technology:
Others
Estimated Revenue:
$1B to $10B
Founded Date:
1987-06-22
Last Funding Date:
1988-01-01
Headquarters:
Foster City, California, United States
Acquisitions Number:
Made Acquisitions
Funding Status:
IPO
Last Funding Type:
Seed
Employee Number:
10001+
Number Of Exists:
10
Industry:
Biopharma, Biotechnology, Commercial, Health Care, Manufacturing, Pharmaceutical
Investors Number:
39